Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy
Marta Libura(Medical University of Warsaw), W Wiktor-Jędrzejczak(Medical University of Warsaw), Monika Paluszewska, Małgorzata Paszkowska‐Kowalewska(Medical University of Warsaw), Sylwia Czekalska(Jagiellonian University), Anna Pastwińska(The Maria Sklodowska-Curie National Research Institute of Oncology), Joanna Trubicka(Children's Memorial Health Institute), Hanna Makuch‐Łasica, Anna Kopińska(Medical University of Silesia), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Anna Czyż(Wroclaw Medical University), Agnieszka Piekarska(Gdańsk Medical University), Tomasz Wróbel, Krzysztof Mądry(Medical University of Warsaw), Izabela Florek(Jagiellonian University), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Krzysztof Lewandowski(Poznan University of Medical Sciences), Bożena Jaźwiec(University of Wrocław), Grzegorz Basak(Medical University of Warsaw), Paweł Tyrna(Medical University of Warsaw), Lidia Gil(Poznan University of Medical Sciences), Przemysław Juszczyński(Instytut Hematologii i Transfuzjologi), Grzegorz Helbig(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Olga Haus(Collegium Medicum in Bydgoszcz), Marta Więsik(Medical University of Warsaw), Magdalena Dutka(Gdańsk Medical University), Tomasz Gromek(Medical University of Lublin), Jerzy Hołowiecki(Medical University of Silesia), Magdalena Zawada(Jagiellonian University), Beata Piątkowska‐Jakubas(Jagiellonian University), Rafał Machowicz(Medical University of Warsaw), Katarzyna Borg, Michał Gniot(Poznan University of Medical Sciences), Karolina Karabin(Medical University of Warsaw), Marta Zacharczuk(University of Wrocław), Magdalena Szymańska(Medical University of Warsaw), Agnieszka Tomaszewska(Medical University of Warsaw), Maria Król(Medical University of Warsaw), Katarzyna Kapelko‐Słowik(Wroclaw Medical University), Tomasz Czerw(The Maria Sklodowska-Curie National Research Institute of Oncology)
Cited by 3
Related Papers
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
|New England Journal of Medicine|2007|1.8k
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party
|Blood|2021|714
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
|The Lancet|2021|456